4.7 Article

Infrared Thermal Imaging as a Novel Non-Invasive Point-of-Care Tool to Assess Filarial Lymphoedema

Journal

JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 11, Pages -

Publisher

MDPI
DOI: 10.3390/jcm10112301

Keywords

infrared thermal imaging; lymphatic filariasis; lymphoedema; NTDs; neglected tropical diseases; skin temperature; tissue tonometry; point of care

Funding

  1. GlaxoSmithKline (GSK)

Ask authors/readers for more resources

The use of an infrared thermal imaging camera showed potential in objectively assessing lower-limb lymphoedema in lymphatic filariasis patients. The tool can detect temperature differences by severity of lymphoedema and history of ADLA, helping health workers to identify subclinical cases, predict disease progression, and monitor pathological changes and stage severity following interventions.
Lymphatic filariasis causes disfiguring and disabling lymphoedema, which is commonly and frequently exacerbated by acute dermatolymphangioadenitis (ADLA). Affected people require long-term care and monitoring but health workers lack objective assessment tools. We examine the use of an infrared thermal imaging camera as a novel non-invasive point-of-care tool for filarial lower-limb lymphoedema in 153 affected adults from a highly endemic area of Bangladesh. Temperature differences by lymphoedema stage (mild, moderate, severe) and ADLA history were visualised and quantified using descriptive statistics and regression models. Temperatures were found to increase by severity and captured subclinical differences between no lymphoedema and mild lymphoedema, and differences between moderate and severe stages. Toes and ankle temperatures detected significant differences between all stages other than between mild and moderate stages. Significantly higher temperatures, best captured by heel and calf measures, were found in participants with a history of ADLA, compared to participants who never had ADLA, regardless of the lymphoedema stage. This novel tool has great potential to be used by health workers to detect subclinical cases, predict progression of disease and ADLA status, and monitor pathological tissue changes and stage severity following enhanced care packages or other interventions in people affected by lymphoedema.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available